Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Carbohydrate doai
Patent
1994-11-01
1996-05-28
Robinson, Douglas W.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Carbohydrate doai
514 45, 514 81, 536 2714, 536 274, 536 292, 544262, A61K 3170, A61K 31675, C07D48700
Patent
active
055211623
ABSTRACT:
This invention relates to certain aristeromycin/adenosine derivatives which are useful in inhibiting AdoMet-dependent transmethylation and in the treatment of patients afflicted with neoplastic or viral disease states.
REFERENCES:
patent: 3472837 (1969-10-01), Verheyden et al.
patent: 3825541 (1974-07-01), Vince et al.
patent: 3910885 (1975-10-01), Moffatt et al.
patent: 4321376 (1982-03-01), Otani et al.
patent: 4386093 (1983-05-01), Chiang et al.
patent: 4387228 (1983-06-01), Montgomery et al.
patent: 4423218 (1983-12-01), Otani et al.
patent: 4728736 (1988-03-01), Shealy et al.
patent: 4816575 (1989-03-01), Fukukawa et al.
patent: 4916224 (1990-04-01), Vince et al.
patent: 4954504 (1990-09-01), Chen et al.
patent: 4968690 (1990-11-01), Marquez et al.
Ferrier, "4',5'-Unsaturated Cyclic Compounds," Advances in Carbohydrate Chemistry and Biochemistry, 24, 250-251 (1969).
Bennett et al., "Differences in the Metabolism and Metabolic Effects of the Carbocyclic Adenosine Analogs, Neplanocin A and Aristeromycin," Mol. Pharmacol., 29, 383-390 (1986).
DeClercq, "S-Adenosylhomocysteine Hydrolase Inhibitors as Broad Spectrum Antiviral Agents," Biochem. Pharmacology, 36, 2567-2575 (1987).
Brimacombe, "The Synthesis of Rare Sugars," Angewandte Chemie. Intl. Ed., 8(6), 401-468 (1969).
Cook et al., "Nucleoside 4',5'-Enol Acetates. Synthesis and Chemistry of a Unique Uridine O.sup.2, 4'-Anhydronucleoside," J. Am. Chem. Soc., 101, 1554-1564 (1979).
Jenkins et al., "4'-Substituted Nucleosides. 2. Synthesis of the Nucleoside Antibiotic Nucleocidin," J. Am. Chem. Soc., 98(11), 3346-3357 (1976).
Richards et al., "Synthesis of 4'-Methoxyadenosine and Related Compounds," Carbohydrate Research, 100, 315-329 (1982).
Verheyden et al., "Synthesis of Certain 4'-Substituted Nucleosides," Ann. N.Y. Acad. Sci., 225, 151-165 (1975).
Aarbakke et al., "Induction of HL-60 Cell Differentiation by 3-Deaza(.+-.)-Aristeromycin, an Inhibitor of S-Adenosylhomocysteine Hydrolase," Cancer Res., 46, 5469-5472 (1986).
Montgomery et al., "Carbocyclic Analogue of 3-Deazaadenosine: A Novel Antiviral Agent Using S-Adenosylhomocystgeine Hydrolase as a Pharmacological Target," J. Med. Chem., 25, 626-629 (1982).
DeClercq et al., "Broad-Spectrum Antiviral Activity of the Carbocyclic Analog of 3-Deazaadenosine," Antiviral Res., 3, 17-24 (1983).
Baker et al, "5'-Substituted-5'-Deoxy Nucleosides," Tetrahedron, 30, 2939-2942 (1974).
Craig et al., "Synthesis of 9-[5-(Alkylthio)-5-deoxy-.beta.-D-erythro-pent-4-enofuranosyl)adenines as Potential Inhibitors of Transmethylation," J. Org. Chem. 51, 1258-1264 (1986).
Palmer et al., "The Mechanism of Action of S-Adenosylhomocyteinase," J. Biol. Chem., 254(4), 1217-1225 (1979).
Jarvi Esa T.
McCarthy James R.
Prakash Nellikunja J.
Crane L. Eric
Merrell Pharmaceuticals Inc.
Robinson Douglas W.
Wille Louis J.
LandOfFree
Aristeromycin analogues of 4',5'-didehydro-5'-fluoro-adenosine a does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Aristeromycin analogues of 4',5'-didehydro-5'-fluoro-adenosine a, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Aristeromycin analogues of 4',5'-didehydro-5'-fluoro-adenosine a will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-786767